HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wen-Cheng Xiong Selected Research

Agrin

1/2019A mechanism in agrin signaling revealed by a prevalent Rapsyn mutation in congenital myasthenic syndrome.
1/2018Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis.
1/2018Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice.
1/2017Agrin to YAP in Cancer and Neuromuscular Junctions.
1/2014Autoantibodies to agrin in myasthenia gravis patients.
4/2012Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wen-Cheng Xiong Research Topics

Disease

13Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 11/2004
12Schizophrenia (Dementia Praecox)
01/2020 - 06/2008
5Alzheimer Disease (Alzheimer's Disease)
01/2020 - 05/2011
5Myasthenia Gravis
01/2018 - 04/2012
4Neurodegenerative Diseases (Neurodegenerative Disease)
08/2021 - 04/2006
4Bone Resorption
06/2021 - 09/2003
4Neoplasms (Cancer)
01/2017 - 05/2005
3Gliosis
08/2021 - 02/2014
3Inflammation (Inflammations)
01/2021 - 01/2011
3Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
01/2021 - 01/2019
3Mental Disorders (Mental Disorder)
01/2018 - 03/2013
3Muscle Weakness
01/2018 - 12/2013
3Diabetes Complications
10/2011 - 04/2006
2Stroke (Strokes)
01/2021 - 01/2018
2Blindness (Hysterical Blindness)
01/2020 - 02/2014
2MASS syndrome
01/2019 - 07/2014
2Ischemia
01/2018 - 07/2004
1Perinatal Death
08/2021
1Moyamoya Disease (Moya-Moya Disease)
01/2021
1Down Syndrome (Down's Syndrome)
01/2021
1Seizures (Absence Seizure)
01/2021
1Epilepsy (Aura)
01/2021
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2021
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2021
1Cognitive Dysfunction
01/2020
1Inborn Genetic Diseases (Disease, Hereditary)
01/2020
1Atrophy
01/2020
1Neurobehavioral Manifestations
01/2020
1Hydrocephalus (Hydrocephaly)
01/2020
1Laminopathies
01/2020
1Microphthalmos
01/2020
1Persistent Hyperplastic Primary Vitreous
01/2020
1Osteoporosis
01/2020
1Ischemic Stroke
11/2019
1Autism Spectrum Disorder
10/2019
1Autistic Disorder (Autism)
10/2019
1Insulin Resistance
01/2019
1Infections
01/2019
1Hypertrophy
01/2019
1Brain Injuries (Brain Injury)
01/2018
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2018
1Bipolar Disorder (Manic Depressive Psychosis)
01/2018
1Hepatocellular Carcinoma (Hepatoma)
01/2017
1Hereditary Corneal Dystrophies
01/2017
1Glioma (Gliomas)
01/2017
1Nervous System Diseases (Neurological Disorders)
12/2016
1Parkinson Disease (Parkinson's Disease)
07/2015

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
08/2021 - 02/2007
13neogeninIBA
01/2021 - 11/2005
6NetrinsIBA
01/2021 - 01/2008
6Netrin ReceptorsIBA
01/2021 - 11/2004
6AgrinIBA
01/2019 - 04/2012
6Neuregulin-1 (Neuregulin 1)IBA
01/2018 - 06/2008
5AntibodiesIBA
01/2018 - 04/2012
4Amyloid (Amyloid Fibrils)IBA
06/2021 - 05/2011
4LigandsIBA
01/2021 - 04/2006
4LDL Receptors (LDL Receptor)IBA
01/2018 - 12/2013
4Phosphotransferases (Kinase)IBA
01/2017 - 09/2003
3peripheral membrane protein 43KIBA
01/2020 - 12/2016
3Receptor for Advanced Glycation End ProductsIBA
10/2011 - 04/2006
2HepcidinsIBA
06/2021 - 04/2010
2Glutamic Acid (Glutamate)FDA Link
01/2021 - 01/2018
2Retinaldehyde (Retinal)IBA
01/2020 - 02/2014
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 10/2005
2gamma-Aminobutyric Acid (GABA)IBA
10/2014 - 01/2010
2AutoantibodiesIBA
01/2014 - 04/2012
2Lipoproteins (Lipoprotein)IBA
01/2014 - 04/2012
2Immunoglobulins (Immunoglobulin)IBA
01/2011 - 04/2006
2Oxidants (Oxidizing Agents)IBA
07/2006 - 05/2005
1DNA-Binding Proteins (DNA Binding Protein)IBA
08/2021
1SmokeIBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1ParvalbuminsIBA
01/2021
1Ligases (Synthetase)IBA
01/2021
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2021
1Lamin Type A (Lamin A)IBA
01/2020
1pexidartinibIBA
01/2020
1UbiquitinIBA
01/2020
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2020
1Cullin Proteins (Cullins)IBA
01/2020
1Macrophage Colony-Stimulating FactorIBA
01/2020
1erucylphosphocholineIBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1CX3C Chemokine Receptor 1IBA
11/2019
1Coenzyme A (CoA)IBA
10/2019
1CortactinIBA
10/2019
1Fatty Acids (Saturated Fatty Acids)IBA
01/2019
1EnzymesIBA
01/2019
1LipidsIBA
01/2019
1Insulin (Novolin)FDA Link
01/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1Adenosine Triphosphate (ATP)IBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1NeuregulinsIBA
01/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
01/2018
1Membrane Transport Proteins (Biological Pump)IBA
01/2017
1hydroxide ionIBA
01/2017
1Netrin-1IBA
01/2017
1SynucleinsIBA
07/2015